OPTIC ATROPHY

This adverse event was reported 1630 times

OPTIC ATROPHY is most prevalent among patients taking these drugs:

# Drug Count Frequency
0 SUMATRIPTAN AND NAPROXEN SODIUM 1 0.0455
1 VORETIGENE NEPARVOVEC-RZYL 3 0.0197
2 DINUTUXIMAB 8 0.0093
3 IOBENGUANE I-123 1 0.0088
4 FOSAMPRENAVIR CALCIUM 1 0.0076
5 CHLOROQUINE PHOSPHATE 5 0.0076
6 PIMOZIDE 3 0.0062
7 SOMAPACITAN-BECO 1 0.0055
8 ETOPOSIDE PHOSPHATE 9 0.0055
9 VINBLASTINE SULFATE 10 0.0051
See all drugs enriched for association with OPTIC ATROPHY